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Skin Commensals Amplify the Innate Immune
Response to Pathogens by Activation of Distinct
Signaling Pathways
Ines Wanke1, Heiko Steffen1, Christina Christ1, Bernhard Krismer2, Friedrich Go¨tz3, Andreas Peschel2,
Martin Schaller1 and Birgit Schittek1
Little is known about the impact of different microbial signals on skin barrier organ function and the
interdependency between resident microflora and pathogenic microorganisms. This study shows that
commensal and pathogenic staphylococci differ in their ability to induce expression of antimicrobial
peptides/proteins (AMPs) and activate different signaling pathways in human primary keratinocytes. Whereas
secreted factors of skin commensals induce expression of the AMPs HBD-3 and RNase7 in primary human
keratinocytes via Toll-like receptor (TLR)-2, EGFR, and NF-kB activation, those of pathogenic staphylococci
activate the mitogen-activated protein kinase and phosphatidylinositol 3-kinase/AKT signaling pathways and
suppress NF-kB activation. Interestingly, commensal bacteria are able to amplify the innate immune response of
human keratinocytes to pathogens by increased induction of AMP expression and abrogation of NF-kB
suppression, suggesting that the two activation pathways can act in a synergistic way. These data indicate that
commensal and pathogenic microorganisms evolved specific mechanisms to modulate innate immunity of
the skin.
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INTRODUCTION
Human epidermis consists of a multilayered stratified
epithelium in which keratinocytes represent the major cell
population involved in the first line of defense against
microbial pathogens (Pivarcsi et al., 2005; Cogen et al.,
2008). Keratinocytes actively participate in the innate
immune response by production of cytokines, chemokines
(Fujisawa et al., 1997; Tuzun et al., 2007), and antimicrobial
peptides (AMPs) (Schroder and Harder, 2006). In human skin,
AMPs serve as a first defense line against infection by
pathogenic microorganisms, as they are active against a
broad spectrum of Gram-positive and Gram-negative
bacteria as well as some fungi and enveloped viruses
(Brogden, 2005).
AMPs are expressed either constitutively or upregulated in
response to microbial stimuli such as pathogen-associated
molecular patterns or proinflammatory stimuli (Schroder and
Harder, 2006; Schittek et al., 2008). The most abundant
AMPs produced by human keratinocytes are the human
b-defensins HBD-1, HBD-2, and HBD-3, the cathelicidin
LL-37, and the antimicrobial protein RNase 7 (Fulton et al.,
1997; Schroder and Harder, 2006). Except for HBD-1, which
is constitutively produced at low amounts, the expression of
the other AMPs are induced by inflammatory stimuli such as
pathogenic bacteria or by proinflammatory cytokines (Harder
et al., 2000; Menzies and Kenoyer, 2005; Sorensen et al.,
2005). Contact of cultured differentiated epidermal keratino-
cytes to Staphylococcus aureus upregulates the expression of
HBD-2, HBD-3, and LL-37 in keratinocytes (Midorikawa
et al., 2003; Menzies and Kenoyer, 2005). HBD-1 and
HBD-2 show only a low activity against S. aureus and other
Gram-positive bacteria, but may have additive or synergistic
antistaphylococcal activity with other AMPs (Midorikawa
et al., 2003; Chen et al., 2005). On the other hand, HBD-3
and RNase 7 are highly active against S. aureus and other
Gram-positive microorganisms (Garcia et al., 2001; Harder
et al., 2001; Harder and Schroder, 2002).
Although human skin is constantly exposed to a variety of
potential pathogenic microorganisms, it gets only rarely infected
(Harder and Schroder, 2005; Schittek et al., 2008). Furthermore,
human skin is selectively colonized by commensal bacteria,
especially by S. epidermidis, whereas S. aureus is only rarely
found on healthy human skin (Cogen et al., 2008). Astonish-
ingly, the response of keratinocytes to colonization with
commensal bacteria and the influence of commensals on the
response to pathogens are not well understood.
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In this study, we asked whether human keratino-
cytes respond differentially with respect to the induction of
gene expression of the AMPs, HBD-1, HBD-2, HBD-3, and
RNase7, upon contact with the pathogen S. aureus and the
commensal S. epidermidis. Furthermore, we analyzed the
signal transduction pathways that are activated in keratino-
cytes upon contact with these microorganisms. Finally, we
examined the influence of commensals on the keratinocyte
response to pathogenic staphylococci.
RESULTS
Differential induction of AMPs by commensal and pathogenic
staphylococci in human primary keratinocytes
We could show that commensal and pathogenic staphylococci
are both able to adhere to human keratinocytes, and that the
viability of the keratinocytes up to 24hours after stimulation
with live S. aureus or S. epidermidis was not affected (490%
viable keratinocytes, data not shown). Furthermore, S. aureus
is able to induce the expression of the AMPs HBD-2, HBD-3,
and RNase7 time dependently in differentiated primary
keratinocytes with the highest expression 24hours after
bacterial stimulation (HBD-2: 75-fold; HBD-3: 98-fold; and
RNase7: 62-fold), whereas the expression of HBD-1 was not
significantly increased (Figure 1a). Interestingly, S. epidermidis
induces the expression of HBD-2 up to 30-fold 24hours after
bacterial stimulation, whereas HBD-3 and RNase7 expression
is only slightly induced (HBD-3: 4.2-fold; and RNase7: 7.8-
fold, 24 hours after bacterial stimulation; Figure 1b).
Secreted factors of S. aureus are able to induce the expression
of HBD-3 and RNase 7 in primary human keratinocytes and
enhance their ability to kill S. aureus
Next, we analyzed whether the induction of AMP expres-
sion in keratinocytes is mediated by soluble factors released
by staphylococci or by bacterial contact. As shown in
Figure 1c–e, HBD-2 expression was significantly induced
in differentiated keratinocytes by live staphylococci
(S. epidermidis and S. aureus) alone, not by heat-killed
bacteria or bacterial-conditioned medium (BCM). Further-
more, both live bacteria and BCM from S. aureus (SA113
wild-type strain and a protein A mutant) were able to
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Figure 1. Differential induction of antimicrobial peptides/proteins (AMPs) by staphylococcal preparations in differentiated human primary keratinocytes
and influence on bacterial viability. (a–e) RNA expression of human b-defensin (HBD)-1, HBD-2, HBD-3, and RNase 7 compared with the unstimulated
control set as 1. (a, b) Ca2þ -differentiated primary keratinocytes were stimulated by live (a) Staphylococcus aureus 113 Dspa or (b) S. epidermidis 1457 for 6, 12,
18, or 24 hours. (c–e) Differentiated human primary keratinocytes were infected by either (c) live or (d) heat-killed bacteria, or with (e) bacterial-conditioned
medium (BCM) of S. aureus 113 Dspa or S. epidermidis 1457. (f) Percentages of counted colony-forming units (CFUs) normalized to untreated control cells
of an antimicrobial test with lysates from human primary keratinocytes challenged with BCM from S. epidermidis 1457 or S. aureus 113 Dspa with the
same strains.
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differentially induce expression of HBD-3 and RNase 7
compared with S. epidermidis. HBD-1 expression was
only poorly affected by bacterial stimulation (Figure 1c–e;
Supplementary Figure S1A online). Interestingly, stimulation
of primary keratinocytes with S. aureus BCM enhanced the
ability of these cells to kill S. aureus, but not S. epidermidis,
whereas S. epidermidis BCM did not significantly increase
antimicrobial activity against S. aureus and S. epidermidis
(Figure 1f).
Several strains of S. aureus able to colonize atopic skin are able
to highly induce HBD-3 and RNase 7 expression in primary
keratinocytes
To prove if the differential induction of HBD-3 and RNase7
expression by S. aureus is a general phenomenon, we tested
BCM of 12 different strains or isolates of S. epidermidis, 12
nondefined commensals from people with healthy skin, and
30 S. aureus laboratory strains or clinical isolates of patients
with atopic dermatitis. Figure 2a and b demonstrates that the
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Figure 2. Human b-defensin-3 (HBD-3) and RNase 7 expression is induced in differentiated primary keratinocytes by several skin colonizing strains
of Staphylococcus aureus. (a–e) Relative RNA expression of the indicated antimicrobial peptides/proteins (AMPs) compared with the unstimulated control
set as 1. Expression of (a) HBD-3 or (b) RNase7 in differentiated primary human keratinocytes after 24 hours of stimulation with bacterial-conditioned
medium (BCM) of 12 different strains and isolates of S. epidermidis, 12 unidentified commensals from people with healthy skin, and 30 strains and isolates
of S. aureus. Basal AMP expression in Ca2þ -differentiated compared with undifferentiated primary human keratinocytes. Successful differentiation was
verified by expression of involucrin (inlet). (c) Comparison of Ca2þ -differentiated and undifferentiated primary human keratinocytes and HaCaT after 24 hours
of challenge with BCM of (d) S. aureus 113 Dspa or (e) S. epidermidis 1457.
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different S. epidermidis strains are significantly less able
to induce expression of HBD-3 (mean 7.8) and RNase7
(mean 6.3) than the S. aureus strains (mean 26.9 for HBD-3
and 19.3 for RNase7). These data indicate that several
S. aureus strains including clinical isolates are able to induce
a higher expression level of HBD-3 and RNase7 in primary
human keratinocytes than S. epidermidis laboratory strains
and clinical isolates. Interestingly, comparison of 15 different
nasal isolates of S. epidermidis with the corresponding nasal
isolates of S. aureus from the same healthy individuals
indicated that these S. aureus strains induce similar low
levels of HBD-3 and RNase7 expression in primary human
keratinocytes as the corresponding S. epidermidis strains
(Supplementary Figure S2 online).
Induction of AMP expression by staphylococci in human
keratinocytes is dependent on the differentiation state of the
cells
We were interested whether the differentiation state of primary
human keratinocytes influences AMP expression. Ca2þ -
induced differentiation increased gene expression of the
differentiation marker involucrin and upregulated the expression
of HBD-1 and HBD-2 up to 12-fold (Figure 2c), which confirms
previous studies (Liu et al., 2002; Harder et al., 2004; Menzies
and Kenoyer, 2005). Interestingly, only Ca2þ -differentiated
primary keratinocytes, and not undifferentiated primary human
keratinocytes and the keratinocyte cell line HaCaT, did respond
to stimulation by secreted factors of S. aureus (Figure 2d) and—
to a lesser extent—of S. epidermidis (Figure 2e) via increased
expression of HBD-3 and RNase7. The same results were
obtained after stimulation with live staphylococci (data not
shown). These data clearly indicate that there is a differential
sensitivity toward staphylococci stimulation in human keratino-
cytes depending on the state of differentiation.
S. epidermidis amplifies the innate immune response of
keratinocytes
In a physiological situation, pathogenic microorganisms
infect human skin that is already colonized with commensal
bacteria. Therefore, we analyzed induction of AMP expres-
sion in differentiated primary human keratinocytes after
stimulation with BCM of S. epidermidis or S. aureus alone,
together, or after sequential stimulation. Interestingly, RNA
expression of HBD-3 and RNase7 was significantly upregu-
lated by stimulation with BCM of commensal and pathogenic
staphylococci together or after sequential bacterial stimula-
tion (Figure 3a). We could confirm increased HBD-3
expression on protein level (Figure 3b). HBD-2 expression
was not induced under these conditions since BCM was used.
These data indicate that S. epidermidis sensitizes human
keratinocytes toward S. aureus and amplifies the innate
immune response of primary human keratinocytes.
TLR-2 and EGFR signaling are involved in the induction of
HBD-3 and RNase7 expression by secreted factors of
S. epidermidis, but not of S. aureus
Differentiated primary human keratinocytes express Toll-like
receptors (TLRs) 1, 2, 3, 5, 6, and 9 and Nod1, whereas
expression of TLRs 4, 7, and 8 were not detectable.
Stimulation of keratinocytes with BCM of S. aureus or
S. epidermidis resulted in a significantly decreased expres-
sion of TLRs 5 and 6 and Nod1, and a highly increased
expression of TLR-9, whereas TLR-1 and TLR-3 expres-
sion was decreased by BCM of S. aureus alone, and
TLR-2 expression was increased by treatment with BCM of
S. epidermidis (Figure 4a).
To evaluate whether TLR-2 is involved in AMP induction
by staphylococci, we used a TLR-2-specific blocking anti-
body. The TLR-2/6 ligand Pam2Cys induced expression of
HBD-2, but not of HBD-3 and RNase7 in differentiated
primary keratinocytes that could be reduced by TLR-2
blockade (Figure 4b and c). Interestingly, whereas the expres-
sion of HBD-3 and RNase7 by S. aureus BCM stimulation was
not affected by TLR-2 blockade, the comparatively low
induction of HBD-3 and RNase7 expression by S. epidermi-
dis BCM was significantly reduced after TLR-2 antibody
treatment (Figure 4c). Furthermore, TLR-2 blockade signi-
ficantly reduced induction of HBD-3, but not of RNase7,
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by stimulation with BCM of commensal and pathogenic
staphylococci together (Figure 4c).
EGFR ligands, especially transforming growth factor-a, are
able to induce expression of HBD-3 and RNase7 in
differentiated primary keratinocytes, whereas HBD-2 expres-
sion was not affected (Figure 4b). The TGF-a-induced
expression of HBD-3 and RNase7 could be blocked with
an EGFR blocking antibody (Figure 4e) and gefitinib, an EGFR
tyrosine kinase inhibitor (Figure 4f), whereas the S. aureus
BCM-induced HBD-3 and RNase7 expression could not
be inhibited by EGFR blockade. In contrast, inhibition of
EGFR signaling diminished HBD-3 and RNase7 induction by
S. epidermidis BCM and induction of HBD-3, but not of RNase7
expression after stimulation of primary keratinocytes with BCM
of commensal and pathogenic staphylococci together (Figure 4e
and f). There was no significant difference in AMP induction
after blockade using a wild-type S. aureus strain 113 or a protein
A mutant (Supplementary Figure S1B online).
NF-jB signaling is involved in induction of HBD-3 and RNase7
expression by secreted factors of S. epidermidis, but not of
S. aureus
As it is known that TLR signaling is mainly mediated by
NF-kB activation, we examined the effect of celastrol, a
known inhibitor of NF-kB signaling on HBD-2, HBD-3, and
RNase7 induction. Whereas NF-kB inhibition by celastrol
caused a strong reduction of the Pam2Cys-induced HBD-2
expression, the S. aureus BCM-induced HBD-3 and RNase7
expression was only slightly affected. Interestingly, the
S. epidermidis-induced HBD-3 and RNase7 expression was
inhibited up to 75% after treatment with the NF-kB inhibitor
(Figure 4d). Similar effects were obtained after stimulation
with BCM of commensal and pathogenic staphylococci
together (Figure 4d). The findings for S. aureus and
S. epidermidis BCM could be verified by the use of a second
NF-kB inhibitor, JSH-23 (Figure 5a and b; Supplementary
Figure S1B online). In contrast, HBD-3 and RNase7 induction
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by Staphylococcus epidermidis bacterial-conditioned medium (BCM), but not by S. aureus BCM. (a) Relative RNA expression compared with uninduced
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by both living staphylocci is NF-kB dependent (Figure 5a
and b). This indicates that S. aureus can induce the
expression of HBD-3 and RNase7 by multiple bacterial
factors and signaling pathways.
Secreted factors of S. aureus activate the mitogen-activated
protein kinase and phosphatidylinositol 3-kinase/AKT signaling
pathways and suppress NF-jB activation in primary human
keratinocytes
Next, we examined which signaling pathways were acti-
vated by secreted factors of commensal and pathogenic
staphylococci. S. aureus BCM activated rapidly extracellular
signal-regulated kinase (ERK) and AKT signaling in primary
keratinocytes, whereas S. epidermidis BCM did not result in
phosphorylation of AKT and activated the ERK pathway only
at a late time point (4 hours; Figure 6a). Most interestingly,
the expression of the NF-kB inhibitory protein IkB was
induced by treatment with BCM of S. aureus whereas NF-kB
was not phosphorylated. On the contrary stimulation with
S. epidermidis BCM triggered an up to 2-fold increased
NF-kB phosphorylation (Figure 6a; Supplementary Figure S1C
online). Stimulation of primary keratinocytes with BCM of
S. epidermidis and S. aureus together induced rapid activation of
the phosphatidylinositol 3-kinase/AKT signaling pathway, only
weak activation of ERK, and minimal phosphorylation of NF-kB.
The expression of IkB was not affected (Figure 6a). We
confirmed the results using an NF-kB luciferase reporter gene
construct transfected into these cells. BCM of S. epidermidis is
able to increase NF-kB transcriptional activity up to 2-fold,
whereas BCM of S. aureus reduces NF-kB reporter activity to
50% of the control level (Figure 6b). Interestingly, the
suppression of NF-kB activity by S. aureus was abolished when
the keratinocytes were preincubated with BCM of S. epidermidis
before stimulation with S. aureus (Figure 6b).
DISCUSSION
This study demonstrates that skin keratinocytes discriminate
the presence of commensals from the presence of pathogenic
microorganisms by differential induction of AMPs and
activation of distinct signaling pathways to induce an adapted
and fast innate immune response. The signals delivered by
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secreted factors of commensals alone involve mainly the
classical pathways via TLR-2 and EGFR binding and NF-kB
pathway activation that induce low-level expression of
AMPs, probably sufficient to limit colonization of pathogens
and facilitates their growth on human skin. In contrast,
we describe, to our knowledge previously unreported, that
secreted factors of pathogenic staphylococci are able to
induce an antimicrobial peptide response that is mainly
independent of TLR-2, EGFR, and NF-kB signaling. Further-
more, we observed activation of the phosphatidylinositol
3-kinase and mitogen-activated protein kinase pathways and
inhibition of the NF-kB pathway by S. aureus-secreted
factors. Most importantly, we show that skin commensals
are able to amplify the innate immune response of primary
keratinocytes by increased induction of antimicrobial peptide
expression and abrogation of NF-kB suppression. It is likely
that both mechanisms act in an additive or synergistic way
to amplify immune responses in human skin.
Our studies show that expression of HBD-2 is induced in
primary human keratinocytes by heat-sensitive staphylo-
coccal cell envelope components. We show that HBD-2
expression is induced by Pam2Cys, which is known to
bind to the TLR2/TLR6 heterodimer. In addition, viable
S. epidermidis are also able to induce HBD-2 expression
similar to induction by S. aureus, which confirms previous
studies (Dinulos et al., 2003; Mempel et al., 2003). It is well
known and also confirmed in our studies that the expression
of HBD-2 is inducible by various proinflammatory cytokines
such as tumor necrosis factor and IL-1b or microbial stimuli
such as P. aeruginosa (Harder et al., 1997, 2000, 2001, 2004;
Liu et al., 2002; Sorensen et al., 2003, 2005; Wehkamp et al.,
2006). It has been shown that the p38 mitogen-activated
protein kinase and NF-kB pathways and the activator protein-
1 transcription factor regulate expression of HBD-2, and that
NOD-2 is also involved in the HBD-2 induction in keratino-
cytes (Krisanaprakornkit et al., 2000; Chung and Dale, 2004;
Wehkamp et al., 2004, 2006; Voss et al., 2006). On the other
hand, HBD-2 induction can also be NF-kB and activator
protein-1 independent when epithelial cells are stimu-
lated with other microorganisms (Ogushi et al., 2001;
Krisanaprakornkit et al., 2002; Chung and Dale, 2004). This
indicates that the kind of epithelial stimulation is important
in the determination of the signaling pathway involved in
HBD-2 induction.
It is described that the expression of HBD-3 and RNase7
can be increased by stimulation of keratinocytes with tumor
necrosis factor, IL-1b, IFN-g, or contact with Gram-positive
and Gram-negative bacteria as P. aeruginosa and S. aureus
(Harder et al., 2001; Harder and Schroder, 2002). Binding of
staphylococcal cell wall constituents, especially lipoteichoic
acid, to TLR2 is in part responsible for the induction of
HBD-3 (Menzies and Kenoyer, 2005, 2006). Interestingly,
viable staphylococci are a more potent stimulus for HBD-3
induction than cell wall components, indicating that other
staphylococcal factors, like secreted products, are involved
thereby using another signaling pathway (Menzies and
Kenoyer, 2006). Indeed, our studies indicate that factors
secreted by S. aureus are also able to induce expression of
HBD-3 and RNase7 similar to the expression induced by
viable S. aureus. Interestingly, we could clearly show that the
HBD-3 and RNase7 induction by secreted factors of S. aureus
is independent of TLR-2 and NF-kB activation, whereas
induction of these AMPs by living S. aureus is mainly
NF-kB dependent. Only one study reports involvement
of NF-kB in the regulation of HBD-3 expression. In contrast,
the majority of data failed to show a relevance of NF-kB
in controlling HBD-3 expression (Chung and Dale, 2004;
Menzies and Kenoyer, 2006). Therefore, it seems that HBD-3
expression can be induced by multiple bacterial factors and
several signaling pathways.
Sorensen et al. (2005, 2006) have shown that wounding
of skin stimulated HBD-3 expression via transactivation
of the EGFR. We could verify that HBD-3 expression is
induced in primary keratinocytes by activation of the EGFR
using transforming growth factor-a. In our study we show
that the induction of HBD-3 and RNAse7 by secreted
S. aureus products is independent of EGFR activation, and
the induction mediated by secreted factors of S. epidermidis
involves EGFR activation. Therefore, we propose that there
exist at least two ways in the induction of HBD-3 and RNase7
expression in keratinocytes, and that commensal and
pathogenic staphylococci use different predominant signaling
routes.
It is suggested that HBD-3 is the most efficient AMP
induced by S. aureus in killing S. aureus itself (Kisich et al.,
2007). Moreover, to efficiently colonize epithelia, staphylo-
cocci have evolved mechanisms to resist the innate host
defense. It has been nicely shown that S. epidermidis senses
AMPs by a three-component sensor/regulator system that
upregulates resistance mechanisms to cationic AMPs to
coordinate a directed defensive response (Li et al., 2007b).
Interestingly, S. aureus has a similar AMP sensing system that
is, however, AMP selective (Li et al., 2007a). Our study
indicates that the AMP expression level induced by skin
commensals is too low to influence their survival, whereas
the level induced by S. aureus is able to kill pathogenic, but
not commensal staphylococci. Interestingly, S. aureus strains
able to colonize nasal epithelium of healthy individuals
induce similar low levels of AMPs as the corresponding
S. epidermidis nasal isolates. This indicates that S. aureus
able to colonize healthy human epithelium as the nose must
have probably evolved similar protective mechanisms as
S. epidermidis that are important for their successful skin
colonization: (1) they have only limited capacity to induce
AMPs, and (2) they show increased resistance to skin-derived
AMPs because of an AMP-sensing system.
It has been shown that enteric nonpathogenic probiotic
microorganisms are able to attenuate synthesis of inflamma-
tory effector molecules as IL-6 elicited by diverse pro-
inflammatory stimuli as tumor necrosis factor or pathogenic
microorganisms (Neish et al., 2000). This immunosuppressive
effect involves inhibition of the NF-kB pathway by blockade
of IkB degradation. We find in our system that secreted
factors of S. aureus result in stabilization of IkB and inhi-
bition of NF-kB signaling, whereas secreted S. epidermidis
factors induce activation of NF-kB signaling. Interestingly,
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preincubation of keratinocytes with S. epidermidis BCM
is able to prevent IkB accumulation and abolish NF-kB
suppression seen after S. aureus treatment. Finally, we show
that living S. aureus activate NF-kB signaling in human
keratinocytes, presumably by cell envelope components,
confirming a previous study (Mempel et al., 2003). This
indicates that there is a dichotomy in the signals delivered by
S. aureus to epithelial layers. Secreted bacterial factors
transmit different signals to the epidermal layer than cell
envelope components. The extent to how the NF-kB
signaling pathway is activated might be dependent on the
predominant bacterial stimulus, for example, whether the
epithelial cells come into direct contact with the pathogen or
only with secreted bacterial factors as in the epithelial layers
more downstream.
MATERIALS AND METHODS
Blocking experiments
For antibody blocking experiments, differentiated primary keratino-
cytes were incubated for 2 hours with 10 mgml–1 TLR-2 (Imgenex,
San Diego, CA) or EGFR antibody (Millipore, Schwalbach, Germany)
before stimulation with BCM, 100 ngml–1 Pam2Cys (Genaxxon
Bioscience, Ulm, Germany), or 100 ngml–1 transforming growth
factor-a containing keratinocyte basal medium (Meier et al., 2000)
with 1.7mM CaCl2. Inhibition of NF-kB-dependent transcrip-
tional activation (1 mM celastrol; InvivoGen, Toulouse, France, and
15 mM JSH-23; Calbiochem, Bad Soden, Germany) and EGFR
tyrosine kinase signaling (0.025 mM gefitinib; Bioaffin GmbH,
Kassel, Germany) were executed simultaneously with keratinocyte
stimulation.
Western blot analyses
Preparation of lysates, electrophoresis, and immunoblotting were
performed in accordance with standard protocols. The following
primary antibodies were used: anti-ERK, anti-phospho-ERK (Thr202/
Tyr204), anti-AKT, anti-phospho-AKT (Thr308), anti-NF-kB p65, anti-
phospho-NF-kB p65 (Ser536), anti-IkB-a, and anti-b-actin (Cell
Signaling Technology, Beverly, MA). We used horseradish peroxi-
dase-conjugated secondary antibodies, goat anti-rabbit IgG (Jackson
ImmunoResearch Laboratories, West Grove, PA), or goat anti-mouse
IgG (Bio-Rad, Munich, Germany). ECL Plus (RPN2132, GE Health-
care, Freiburg, Germany) was used as chemiluminescence reagent,
exposure to X-ray film (Eastman Kodak, Rochester, NY) for detection.
ELISA
Stimulated keratinocytes were washed three times with Hank’s
buffered salt solution and fresh medium was added for a period of
4 hours. This supernatant was analyzed by ELISA. Albumin and
human IgG were used to block unspecific binding. Calibration
was carried out using recombinant hBD3 (Peprotech, Hamburg,
Germany). hBD3-antibody (Peprotech), anti-rabbit-biotinylated-anti-
body (DAKO, Hamburg, Germany), streptavidin-AP-conjugate
(Roche, Basel, Switzerland), and p-Nitrophenolphosphat (Sigma,
Munich, Germany) were used for detection.
NF-jB reporter gene assay
Keratinocytes were transiently transfected with 100 ng NF-kB
reporter plasmid (pGL4.32[luc2P/NF-kB-RE/Hygro]; Promega,
Mannheim, Germany) and 25 ng of an internal control pRL-TK-
plasmid using Primefect (Lonza, Basel, Switzerland) transfection
reagent according to the manufacturer’s instructions. After a 24-hour
starvation and differentiation period, keratinocytes were stimulated
for 24 hours and luciferase assay was performed using Dual-
Luciferase Assay (Promega) according to the manufacturer’s instruc-
tions in a Tristar luminometer (Berthold, Bad Wildbach, Germany),
and the firefly luciferase/Renilla luciferase ratio was determined.
Antimicrobial test
The antimicrobial activity of the stimulated keratinocytes was tested
in an adapted colony-forming unit assay. Hypotonic lysis of
stimulated keratinocytes occurred in 1:10 diluted phosphate-
buffered saline with protease inhibitors (complete Mini; Roche)
combined with ultrasonification. The insoluble parts were removed
using centrifugation. The colony-forming unit assay was executed in
a volume of 100ml 1:10 diluted phosphate-buffered saline using
1 105 bacteria and lysate corresponding to 20 mg protein. After
2 hours of incubation at 37 1C and shaking, the bacteria suspension
was diluted and plated on blood agar plates.
Statistical analysis
Statistical analyses were performed using two-tailed unpaired t-test
or for blockade experiments one-tailed unpaired t-test. A probability
value of o0.05 was considered to be statistically significant and
marked by an asterisk.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
This work was supported by the Deutsche Forschungsgemeinschaft SFB 766
and IZKF Tu¨bingen (1596-0) and by SFB685 and BMBF SkinStaph to AP.
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online version of the paper at http://
www.nature.com/jid
REFERENCES
Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic
inhibitors in bacteria? Nat Rev Microbiol 3:238–50
Chen X, Niyonsaba F, Ushio H et al. (2005) Synergistic effect of anti-
bacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme
against Staphylococcus aureus and Escherichia coli. J Dermatol Sci
40:123–32
Chung WO, Dale BA (2004) Innate immune response of oral and foreskin
keratinocytes: utilization of different signaling pathways by various
bacterial species. Infect Immun 72:352–8
Cogen AL, Nizet V, Gallo RL (2008) Skin microbiota: a source of disease or
defence? Br J Dermatol 158:442–55
Dinulos JG, Mentele L, Fredericks LP et al. (2003) Keratinocyte expression of
human beta defensin 2 following bacterial infection: role in cutaneous
host defense. Clin Diagn Lab Immunol 10:161–6
Fujisawa H, Kondo S, Wang B et al. (1997) The expression and modulation of
IFN-alpha and IFN-beta in human keratinocytes. J Interferon Cytokine
Res 17:721–5
Fulton C, Anderson GM, Zasloff M et al. (1997) Expression of natural peptide
antibiotics in human skin. Lancet 350:1750–1
Garcia JR, Jaumann F, Schulz S et al. (2001) Identification of a novel,
multifunctional beta-defensin (human beta-defensin 3) with specific
antimicrobial activity. Its interaction with plasma membranes of Xenopus
www.jidonline.org 389
I Wanke et al.
Skin Commensals Amplify the Innate Immune Response
oocytes and the induction of macrophage chemoattraction. Cell Tissue
Res 306:257–64
Harder J, Bartels J, Christophers E et al. (1997) A peptide antibiotic from
human skin. Nature 387:861
Harder J, Bartels J, Christophers E et al. (2001) Isolation and characterization
of human beta -defensin-3, a novel human inducible peptide antibiotic.
J Biol Chem 276:5707–13
Harder J, Meyer-Hoffert U, Teran LM et al. (2000) Mucoid Pseudomonas
aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-
defensin-2 in respiratory epithelia. Am J Respir Cell Mol Biol 22:714–21
Harder J, Meyer-Hoffert U, Wehkamp K et al. (2004) Differential gene
induction of human beta-defensins (hBD-1, -2, -3, and -4) in
keratinocytes is inhibited by retinoic acid. J Invest Dermatol 123:522–9
Harder J, Schroder JM (2002) RNase 7, a novel innate immune defense
antimicrobial protein of healthy human skin. J Biol Chem 277:46779–84
Harder J, Schroder JM (2005) Psoriatic scales: a promising source for the
isolation of human skin-derived antimicrobial proteins. J Leukoc Biol
77:476–86
Kisich KO, Howell MD, Boguniewicz M et al. (2007) The constitutive
capacity of human keratinocytes to kill Staphylococcus aureus is
dependent on beta-defensin 3. J Invest Dermatol 127:2368–80
Krisanaprakornkit S, Kimball JR, Dale BA (2002) Regulation of human beta-
defensin-2 in gingival epithelial cells: the involvement of mitogen-
activated protein kinase pathways, but not the NF-kappaB transcription
factor family. J Immunol 168:316–24
Krisanaprakornkit S, Kimball JR, Weinberg A et al. (2000) Inducible
expression of human beta-defensin 2 by Fusobacterium nucleatum in
oral epithelial cells: multiple signaling pathways and role of commensal
bacteria in innate immunity and the epithelial barrier. Infect Immun
68:2907–15
Li M, Cha DJ, Lai Y et al. (2007a) The antimicrobial peptide-sensing system
aps of Staphylococcus aureus. Mol Microbiol 66:1136–47
Li M, Lai Y, Villaruz AE et al. (2007b) Gram-positive three-component
antimicrobial peptide-sensing system. Proc Natl Acad Sci USA 104:
9469–74
Liu AY, Destoumieux D, Wong AV et al. (2002) Human beta-defensin-2
production in keratinocytes is regulated by interleukin-1, bacteria, and
the state of differentiation. J Invest Dermatol 118:275–81
Meier F, Nesbit M, Hsu MY et al. (2000) Human melanoma progression
in skin reconstructs: biological significance of bFGF. Am J Pathol
156:193–200
Mempel M, Voelcker V, Kollisch G et al. (2003) Toll-like receptor expression
in human keratinocytes: nuclear factor kappaB controlled gene activa-
tion by Staphylococcus aureus is toll-like receptor 2 but not toll-like
receptor 4 or platelet activating factor receptor dependent. J Invest
Dermatol 121:1389–96
Menzies BE, Kenoyer A (2005) Staphylococcus aureus infection of epidermal
keratinocytes promotes expression of innate antimicrobial peptides.
Infect Immun 73:5241–4
Menzies BE, Kenoyer A (2006) Signal transduction and nuclear responses
in Staphylococcus aureus-induced expression of human beta-defensin 3
in skin keratinocytes. Infect Immun 74:6847–54
Midorikawa K, Ouhara K, Komatsuzawa H et al. (2003) Staphylo-
coccus aureus susceptibility to innate antimicrobial peptides, beta-
defensins and CAP18, expressed by human keratinocytes. Infect Immun
71:3730–9
Neish AS, Gewirtz AT, Zeng H et al. (2000) Prokaryotic regulation of
epithelial responses by inhibition of IkappaB-alpha ubiquitination.
Science 289:1560–3
Ogushi K, Wada A, Niidome T et al. (2001) Salmonella enteritidis FliC
(flagella filament protein) induces human beta-defensin-2 mRNA
production by Caco-2 cells. J Biol Chem 276:30521–6
Pivarcsi A, Nagy I, Kemeny L (2005) Innate immunity in the skin: how
keratinocytes fight against pathogens. Curr Immunol Rev 1:29–42
Schittek B, Paulmann M, Senyurek I et al. (2008) The role of antimicrobial
peptides in human skin and in skin infectious diseases. Infect Disord
Drug Targets 8:135–43
Schroder JM, Harder J (2006) Antimicrobial skin peptides and proteins.
Cell Mol Life Sci 63:469–86
Sorensen OE, Cowland JB, Theilgaard-Monch K et al. (2003) Wound healing
and expression of antimicrobial peptides/polypeptides in human
keratinocytes, a consequence of common growth factors. J Immunol
170:5583–9
Sorensen OE, Thapa DR, Rosenthal A et al. (2005) Differential regulation of
beta-defensin expression in human skin by microbial stimuli. J Immunol
174:4870–9
Sorensen OE, Thapa DR, Roupe KM et al. (2006) Injury-induced innate
immune response in human skin mediated by transactivation of the
epidermal growth factor receptor. J Clin Invest 116:1878–85
Tuzun Y, Antonov M, Dolar N et al. (2007) Keratinocyte cytokine and
chemokine receptors. Dermatol Clin 25:467–76, vii
Voss E, Wehkamp J, Wehkamp K et al. (2006) NOD2/CARD15 mediates
induction of the antimicrobial peptide human beta-defensin-2. J Biol
Chem 281:2005–11
Wehkamp J, Harder J, Wehkamp K et al. (2004) NF-kappaB- and AP-1-
mediated induction of human beta defensin-2 in intestinal epithelial cells
by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium.
Infect Immun 72:5750–8
Wehkamp K, Schwichtenberg L, Schroder JM et al. (2006) Pseudomonas
aeruginosa- and IL-1beta-mediated induction of human beta-defensin-2
in keratinocytes is controlled by NF-kappaB and AP-1. J Invest Dermatol
126:121–7
390 Journal of Investigative Dermatology (2011), Volume 131
I Wanke et al.
Skin Commensals Amplify the Innate Immune Response
